https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/accounts-payable https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/accounts-payable-and-accrued-liabilities-current https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/accounts-payable-and-accrued-liabilities-current-and-noncurrent https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/accounts-payable-current-and-noncurrent https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/accounts-payable-related-parties-current https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/accounts-receivable-related-parties https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/accrued-liabilities-current https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/accrued-liabilities-current-and-noncurrent https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/accumulated-depreciation https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/acquisition-consideration-transferred-liabilities-incurred https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/additional-paid-in-capital https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/allocated-share-based-compensation-expense https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/amortization-of-above-and-below-market-leases https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/amortization-of-debt-discount-premium https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/aoci https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/asset-impairment-charges https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/basic-shares https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/business-acquisition-percentage-of-voting-interests-acquired https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/capital-expenditures https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/cash https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/cash-and-equivalents https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/cash-equivalents-at-carrying-value https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/cash-flow-breakdown https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/common-stock-capital-shares-reserved-for-future-issuance https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/common-stock-shares-subscriptions https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/common-stock-value https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/construction-in-progress-gross https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/convertible-notes-payable https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/convertible-notes-payable-current https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/cost-of-services https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/costs-and-expenses-related-party https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/cover-page-shares-outstanding https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/current-assets https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/current-liabilities https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/debt-conversion-original-debt-interest-rate-of-debt https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/debt-decrease-forgiveness https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/debt-interest-rate-stated-percentage https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/debt-unamortized-discount https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/deferred-tax-assets-operating-loss-carryforwards https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/deposit-liabilities-accrued-interest https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/deposits-assets-current https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/depreciation-and-amortization-expense https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/derivative-fair-value-of-derivative-liability https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/derivative-gain-loss-on-derivative-net https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/derivative-liabilities-current https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/development-stage-enterprise-deficit-accumulated-during-development-stage https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/diluted-shares https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/due-from-affiliate-current https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/due-to-officers-or-stockholders-current https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/due-to-related-parties-current https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/due-to-related-parties-current-and-noncurrent https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/earnings-per-share-basic-and-diluted https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/effective-tax-rate https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/embedded-derivative-fair-value-of-embedded-derivative-liability https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/embedded-derivative-gain-loss-on-embedded-derivative-net https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/equity-issuance-dollar-amount-per-share https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/equity-method-investment-ownership-percentage https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/fair-value-assumptions-expected-volatility-rate https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/fair-value-assumptions-risk-free-interest-rate https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/financing-cash-flow https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/form-d-corporate-securities https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/furniture-and-fixtures-gross https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/gain-loss-on-repurchase-of-debt-instrument https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/gains-losses-on-extinguishment-of-debt https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/general-and-administrative-expense https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/goodwill-impairment-loss https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/income-loss-attributable-to-noncontrolling-interest https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/income-loss-from-attributable-to-noncontrolling-entity https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/income-tax-at-federal-statutory-rate https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/increase-decrease-due-from-affiliates https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/increase-decrease-in-accounts-payable https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/increase-decrease-in-accounts-payable-and-accrued-liabilities https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/increase-decrease-in-accounts-payable-related-parties https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/increase-decrease-in-accrued-liabilities https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/increase-decrease-in-deposit-other-assets https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/increase-decrease-in-due-to-affiliates https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/increase-decrease-in-due-to-related-parties https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/increase-decrease-in-prepaid-expense https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/insider-transactions-preferred https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/insider-transactions-stock-options https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/intangible-assets-net-excluding-goodwill https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/interest-expense https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/interest-expense-other https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/interest-income-expense-net https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/interest-payable-current-and-noncurrent https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/interest-receivable https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/inventory https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/investing-cash-flow https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/issuance-of-stock-and-warrants-for-services-or-claims https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/lease-and-rental-expense https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/leasehold-improvements-gross https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/litigation-settlement-expense https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/machinery-and-equipment-gross https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/manufacturing-costs https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/minority-interest https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/minority-interest-in-net-income-loss-limited-partnerships https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/minority-interest-ownership-percentage-by-parent https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/net-change-in-cash https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/net-income https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/net-income-loss-attributable-to-noncontrolling-interest https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/notes-issued https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/notes-payable https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/notes-payable-current https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/notes-payable-related-parties-classified-current https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/operating-cash-flow https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/operating-costs-and-expenses https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/operating-expenses https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/operating-income https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/operating-lease-payments-due https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/operating-lease-payments-due-current https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/operating-lease-payments-due-in-two-years https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/operating-leases-future-minimum-payments-receivable https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/operating-leases-future-minimum-payments-receivable-current https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/operating-leases-future-minimum-payments-receivable-in-two-years https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/operating-leases-rent-expense-net https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/operating-loss-carryforwards https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/other-asset-impairment-charges https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/other-cost-and-expense-operating https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/other-expenses https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/other-intangible-assets-net https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/other-notes-payable https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/other-prepaid-expense-current https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/payments-for-proceeds-from-previous-acquisition https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/payments-of-capital-distribution https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/payments-to-acquire-businesses-gross https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/payments-to-acquire-mineral-rights https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/payments-to-acquire-productive-assets https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/preferred-shares-facts https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/preferred-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/preferred-stock-shares-authorized https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/preferred-stock-shares-issued https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/preferred-stock-shares-outstanding https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/preferred-stock-shares-subscribed-but-unissued-value https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/preferred-stock-value https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/prepaid-expense-current https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/pretax-income https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/proceeds-from-collection-of-advance-to-affiliate https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/proceeds-from-collection-of-longterm-loans-to-related-parties https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/proceeds-from-contributed-capital https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/proceeds-from-convertible-debt https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/proceeds-from-issuance-of-convertible-preferred-stock https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/proceeds-from-notes-payable https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/proceeds-from-related-party-debt https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/proceeds-from-repayment-of-loans-to-purchase-common-stock https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/proceeds-from-repayments-of-related-party-debt https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/proceeds-from-secured-notes-payable https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/proceeds-from-stock-issued https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/proceeds-from-unsecured-notes-payable https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/profit-loss https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/property-plant-and-equipment-fair-value-disclosure https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/property-plant-and-equipment-gross https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/property-plant-equipment https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/provision-for-doubtful-accounts https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/public-float https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/related-party-transaction-purchases-from-related-party https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/related-party-transaction-rate https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/repayments-of-debt https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/repayments-of-notes-payable https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/repayments-of-related-party-debt https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/research-and-development https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/retained-earnings https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/revenue https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/sale-of-stock-consideration-received-on-transaction https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/sale-of-stock-number-of-shares-issued-in-transaction https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/sale-of-stock-price-per-share https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/sga-expense https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/share-price https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/shareholders-equity https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/shares-authorized https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/shares-issued https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/shares-issued-for-acquisitions https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/shares-issued-price-per-share https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/shares-issued-shares-new-issues https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/shares-issued-shares-other https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/shares-repurchased https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/stock-award-options-grants-in-period-average-exercise-price https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/stock-award-shares-purchased-for-award https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/stock-based-compensation https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/stock-granted-value-share-based-compensation https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/stock-issued-new-shares-sold https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/stock-issued-shares-issued-shares-issued-for-services https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/stock-issued-shares-issued-value-conversion-of-convertible-securities https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/stock-issued-shares-issued-value-issued-for-services https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/stock-issued-shares-issued-value-other https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/stock-issued-shares-issued-value-purchase-of-assets https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/stock-issued-value-of-shares-issued-for-stock-awards https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/stock-options-exercisable-average-exercise-price https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/stock-options-exercisable-number https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/stock-options-grants-in-period-gross https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/stock-options-outstanding-average-exercise-price https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/stock-options-outstanding-intrinsic-value https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/stock-options-outstanding-number https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/stock-options-vested-and-expected-to-vest-outstanding-average-exercise-price https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/stock-options-vested-and-expected-to-vest-outstanding-number https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/stockholders-equity-including-portion-attributable-to-noncontrolling-interest https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/tax-rate-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/total-assets https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/total-liabilities https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/total-liabilities-and-equity https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/treasury-stock-shares https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/value-of-shares-issued-for-acquisitions https://stock.noler.com/us/stock/petlife-pharmaceuticals-inc/weighted-average-number-of-share-outstanding-basic-and-diluted